Agents and Actions

, Volume 9, Issue 1, pp 117–123 | Cite as

Comparative pharmacology of a 1∶10 combination of indomethacin-sodium salicylate

  • E. Ezer
  • É. Pálosi
  • Gy. Hajós
  • B. Rosdy
  • L. Szporny
Immunosuppression and Inflammation


It has been found that gastrointestinal side-effects of indomethacin could be abolished when administered in combination indomethacin: sodium salicylate (ratio 1∶10). In this paper comparative pharmacological data of this combination and its basal compounds are presented. Acute toxicity of the combined preparation was 72 times less in rats than that of indomethacin alone. All therapeutic indexes were markedly increased in the combination of indomethacin-sodium salicylate compared with the separate drug treatments.


Sodium Drug Treatment Indomethacin Salicylate Acute Toxicity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    E. Ezer, É Pálosi, Gy. Hajós andL. Szporny,Antagonism in Gastro-Intestinal Side-Effect Experienced Between Sodium Salicylate and Some Non-Steroid Antiinflammatory Agents, J. Pharm. Pharmae.28, 655 (1976a).Google Scholar
  2. [2]
    E. Ezer, É. Pálosi, Gy. Hajós andL. Szporny,Inhibition of Indomethacin-Induced Small Intestine Ulceration in the Rat, by Sodium-Salicylate. Progress in Peptic Ulcer (1976b). Budapest Publishing House of the Hungarian Academy of Sciences.Google Scholar
  3. [3]
    S. Torgyán, E. Ady, L. Wagner, T. Neumann, G. Béres andM. Csányi,Reduction of Indomethacin-Induced Gastrointestinal Blood Loss by Sodium-Salicylate in Man, Int. J. Clin. Pharmac., Ther. Toxicol. (in press 1978).Google Scholar
  4. [4]
    E. Sigmund, R. Cadmus andLu Go,A Method for Evalaution both Non-Narcotic and Narcotic Analgesics, Proc. Soc. exp. Biol. Med.95, 729 (1957).PubMedGoogle Scholar
  5. [5]
    C. V. Winder, J. Wax, L. Scotti, R. Schesser, E. Jones andF. Schort,Anti-Inflammatory Antipyretic and Antinociceptive Properties of N′-(2,3-xylyl)anthranilic Acid (Mefenamic Acid), J. Pharmac. exp. Ther.138, 405 (1962).Google Scholar
  6. [6]
    C. A. Winter, E. A. Risley andG. W. Nuss,Anti-Inflammatory and Antipyretic Activities of Indomethacin, J. Pharmac. exp. Ther.141, 369–375 (1963).Google Scholar
  7. [7]
    R. B. Newbold,Chemotherapy of Arthritis Induced in Rats by Mycobacterial Adjuvant, Brit. J. Pharm.21, 127 (1963).PubMedGoogle Scholar
  8. [8]
    E. Ezer andL. Szporny,Complementary Method for the Quantitative Evaluation of Rat Stomach with Shay-Ulcer, J. Pharm. Pharmac.27, 866–867 (1975).Google Scholar
  9. [9]
    Y. H. Lee, K. Mallison andW. D. Cheng,The Effects of Anti-Ulcer Agents on Indomethacin-Induced Gastric Ulceration in the Rat, Arch. int. Pharmacodyd.19, 370–377 (1971).Google Scholar
  10. [10]
    H. B. Hucker, A. G. Zacchei, S. V. Cox, D. A. Brodie andN. H. R. Cantwell,Studies on the Absorption, Distribution and Excretion of Indomethacin in Various Species, J. Pharmac. exp. Ther.153, 237–250 (1966).Google Scholar
  11. [11]
    D. W. Yesair, M. Callahan, L. Remington andC. J. Kensler,Comparative Effects of Salicylic Acid, Phenylbutazone, Probenecid, and Other Anions on the Metabolism, Distribution, and Excretion of Indomethacin by Rats, Biochem. Pharmacol.19, 1591–1600 (1970).CrossRefPubMedGoogle Scholar
  12. [12]
    G. D. Champion, H. E. Paulus, E. Mongan, R. Okun, C. M. Pearson andE. Sarkissian,Effect of Aspirin on Serum Indomethacin, Clin. Pharmacol. Ther.13, 239–244 (1972).PubMedGoogle Scholar
  13. [13]
    B. Lindquist, K. M. Jensen, H. Johansson andT. Hansen,Effect of Concurrent Administration of Aspirin and Indomethacin on Serum Concentrations, Clin. Pharmacol. Ther.15, 247–252 (1974).PubMedGoogle Scholar
  14. [14]
    E. Kaldestad, T. Hansen andH. K. Brath,Interaction of Indomethacin and Acetyl Salicylic Acid as Shown by the Serum Concentrations of Indomethacin as Salicylate, Europ. J. Clin. Pharmacol.9, 199–207 (1975).CrossRefGoogle Scholar
  15. [15]
    P. M. Brooks, J. J. Walker, M. A. Bell, W. W. Buchanan andA. R. Rhymer,Indomethacin-Aspirin Interaction: A Clinical Appraisal, Brit. Med. J.113, 69–71 (1975).Google Scholar
  16. [16]
    J. R. Vane,Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-Like Drugs, Nature New Biol.231, 232–236 (1971).PubMedGoogle Scholar
  17. [17]
    A. Roberts,Effects of Prostaglandins on the Stomach and the Intestine, Prostaglandins6, 523–532 (1974).PubMedGoogle Scholar
  18. [18]
    M. J. H. Smith, A. W. Ford-Hutchinson andP. N. Elliott,Prostaglandins and the Antiinflammatory Activities of Aspirin and Sodium Salicylate, J. Pharm. Pharmac.21, 122–124 (1975).Google Scholar
  19. [19]
    F. Awouters, C. J. E. Niemegeers, F. M. Lenaerts andP. A. J. Janssen,Delay of Castor Oil Diarrhoea in Rats: A New Way to Evaluate Inhibitors of Prostaglandin Biosynthesis, J. Pharm. Pharmac.30, 41–45 (1978).Google Scholar

Copyright information

© Birkhäuser-Verlag 1979

Authors and Affiliations

  • E. Ezer
    • 1
  • É. Pálosi
    • 1
  • Gy. Hajós
    • 1
  • B. Rosdy
    • 1
  • L. Szporny
    • 1
  1. 1.Pharmacological LaboratoryChemical Works of Gedeon Richter Ltd.Budapest

Personalised recommendations